GlycoMimetics Enrolls First Patient in Global Phase 3 Clinical Trial of Uproleselan in Relapsed/Refractory Acute Myeloid Leukemia
Fortune Minerals Reports Successful NICO Project Bismuth Test Work Results for the Planned Alberta Refinery